Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2023-05-23
DOI
10.1080/03602532.2023.2215478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence and risk factors of drug‐induced liver injury
- (2022) Xiaoyun Li et al. LIVER INTERNATIONAL
- Anti-tuberculosis treatment strategies and drug development: challenges and priorities
- (2022) Véronique A. Dartois et al. NATURE REVIEWS MICROBIOLOGY
- Drug-Induced Liver Injury
- (2022) Cathy McAtee Critical Care Nursing Clinics of North America
- NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
- (2022) Luis Jaramillo‐Valverde et al. Molecular Genetics & Genomic Medicine
- Hepatoprotective Effects of Phloridzin against Isoniazid-Rifampicin Induced Liver Injury by Regulating CYP450 and Nrf2/HO-1 Pathway in Mice
- (2022) Jiao Yang et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Exploration of the underlying mechanisms of isoniazid/rifampicin‐induced liver injury in mice using an integrated proteomics and metabolomics approach
- (2022) Yanqing Song et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis
- (2022) Christina Chou et al. JOURNAL OF VIRAL HEPATITIS
- Boldine treatment protects acetaminophen‐induced liver inflammation and acute hepatic necrosis in mice
- (2021) Devaraj Ezhilarasan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Gallic acid attenuates isoniazid and rifampicin-induced liver injury by improving hepatic redox homeostasis through influence on Nrf2 and NF-κB signalling cascades in Wistar Rats
- (2021) Sukumaran Sanjay et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
- (2021) Qiang Su et al. MEDIATORS OF INFLAMMATION
- The application of cytokeratin-18 as a biomarker for drug-induced liver injury
- (2021) Samantha Korver et al. ARCHIVES OF TOXICOLOGY
- Metabolism and Hepatotoxicity of Pyrazinamide, an Antituberculosis Drug
- (2021) Zahir Hussain et al. DRUG METABOLISM AND DISPOSITION
- PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue
- (2021) Chen Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms
- (2021) Devaraj Ezhilarasan TOXICOLOGY
- Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats
- (2021) Khalid Mohammed Naji et al. BMC Pharmacology & Toxicology
- Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management
- (2021) HK Björnsson et al. European Journal of Internal Medicine
- Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space
- (2021) Ezhilarasan Devaraj et al. HEPATOLOGY
- Co-drug of isoniazid and sulfur containing antioxidant for attenuation of hepatotoxicity and treatment of tuberculosis
- (2020) Neha V. Bhilare et al. DRUG AND CHEMICAL TOXICOLOGY
- NRF2, a Transcription Factor for Stress Response and Beyond
- (2020) Feng He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- Pharmacokinetics of isoniazid: The good, the bad, and the alternatives
- (2019) Emily R. Erwin et al. TUBERCULOSIS
- Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway
- (2019) Zhi-li Jia et al. CHEMOSPHERE
- Drug-Induced Liver Injury — Types and Phenotypes
- (2019) Jay H. Hoofnagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB Trial
- (2019) Kogieleum Naidoo et al. CLINICAL INFECTIOUS DISEASES
- Dapsone-induced hepatic complications: it’s time to think beyond methemoglobinemia
- (2019) Devaraj Ezhilarasan DRUG AND CHEMICAL TOXICOLOGY
- Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury
- (2019) Einar S. Björnsson Clinics in Liver Disease
- Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
- (2018) Conor Duncan Tweed et al. BMC Medicine
- Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
- (2018) Devaraj Ezhilarasan et al. Hepatobiliary & Pancreatic Diseases International
- Isoniazid induces apoptosis: Role of oxidative stress and inhibition of nuclear translocation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
- (2018) Ajeet Kumar Verma et al. LIFE SCIENCES
- Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells
- (2018) Xiaoyu Qu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice
- (2018) Jing Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
- (2018) Dick Menzies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-induced liver injury: recent advances in diagnosis and risk assessment
- (2017) Gerd A Kullak-Ublick et al. GUT
- Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid
- (2017) A Rawat et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Classifying new anti-tuberculosis drugs: rationale and future perspectives
- (2017) Simon Tiberi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice
- (2017) Ju-Hyun Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
- (2017) Andrea Iorga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients
- (2017) Harshad Devarbhavi et al. LIVER INTERNATIONAL
- Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway
- (2017) Hong-li Guo et al. TOXICOLOGY
- Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach
- (2017) He Zhao et al. Toxicology Research
- Mechanism of isoniazid-induced hepatotoxicity: then and now
- (2016) Imir Metushi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin
- (2016) Ramanathan Raghu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Drug-induced steatohepatitis
- (2016) Ajit Dash et al. Expert Opinion on Drug Metabolism & Toxicology
- Hesperidin Alleviates Oxidative Stress and Upregulates the Multidrug Resistance Protein 2 in Isoniazid and Rifampicin-Induced Liver Injury in Rats
- (2016) Guoqiang Zhang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome
- (2016) Andrew E. Libby et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor γ in Mouse Liver
- (2016) Jia-Hui Huang et al. PLoS One
- Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport
- (2016) Hong-Li Guo et al. TOXICOLOGICAL SCIENCES
- Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury
- (2016) Chao Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Isoniazid metabolism and hepatotoxicity
- (2016) Pengcheng Wang et al. Acta Pharmaceutica Sinica B
- Isoniazid-induced Acute Liver Failure during Preventive Therapy for Latent Tuberculosis Infection
- (2015) Shoichi Miyazawa et al. INTERNAL MEDICINE
- Hepatotoxicity mechanisms of isoniazid: A mini-review
- (2015) Hozeifa M. Hassan et al. JOURNAL OF APPLIED TOXICOLOGY
- Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis
- (2015) Ajeet Kumar Verma et al. Redox Biology
- Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
- (2014) Neha Singla et al. TUBERCULOSIS
- The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients
- (2014) Camila Zaverucha-do-Valle et al. TUBERCULOSIS
- Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity
- (2013) Tung-Yuan Shih et al. AAPS Journal
- A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide
- (2013) Tung-Yuan Shih et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity
- (2013) Tung-Yuan Shih et al. CURRENT DRUG METABOLISM
- Nuclear erythroid 2-related factor 2: A novel potential therapeutic target for liver fibrosis
- (2013) Jing-Jing Yang et al. FOOD AND CHEMICAL TOXICOLOGY
- N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians
- (2013) S. V. Rana et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Protective Effects of Metallothionein on Isoniazid and Rifampicin-Induced Hepatotoxicity in Mice
- (2013) Yong Lian et al. PLoS One
- Hepatocyte Growth Factor Protects Against Isoniazid/Rifampicin-Induced Oxidative Liver Damage
- (2013) Cristina Enriquez-Cortina et al. TOXICOLOGICAL SCIENCES
- Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury
- (2012) Harshad Devarbhavi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs
- (2012) Julián G Chamorro et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Bile acid transporters and regulatory nuclear receptors in the liver and beyond
- (2012) Emina Halilbasic et al. JOURNAL OF HEPATOLOGY
- CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid
- (2012) Jie Cheng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice
- (2011) Xi Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of oxidative stress and nitric oxide in the protective effects of α-lipoic acid and aminoguanidine against isoniazid–rifampicin-induced hepatotoxicity in rats
- (2010) Evan I. Saad et al. FOOD AND CHEMICAL TOXICOLOGY
- Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
- (2010) Karima Begriche et al. JOURNAL OF HEPATOLOGY
- Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation
- (2010) Philippe Ichai et al. LIVER TRANSPLANTATION
- Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model
- (2008) Shahrzad Tafazoli et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures
- (2007) C Shen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Isoniazid-rifampicin induced lipid changes in rats
- (2007) R. Pal et al. CLINICA CHIMICA ACTA
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More